Wednesday, October 28, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

October 26, 2026: PSM files citizen petition asking FDA not to allow compounding of peptides

The Partnership for Safe Medicines filed a citizen petition on October 16, 2026, asking the FDA not to allow the compounding of six peptides recommended by the Pharmacy…

DO
By Daniel Okafor · Regulatory Correspondent
Oct 26 03:00 ETSource: Partnership for Safe Medicines

From the source

October 26, 2026: PSM files citizen petition asking FDA not to allow compounding of peptides

The Partnership for Safe Medicines filed a citizen petition on October 16, 2026, asking the FDA not to allow the compounding of six peptides recommended by the Pharmacy Compounding Advisory Committee (PCAC) in July. BPC-157, KPV, TB-500, MOTS-c, emideltide, and semax are untested and poorly defined, and making them easier to compound is a threat to public safety.

Read at safemedicines.org
PeptiPrescribed peptides from $99/moSee all →